Zeev Bronfeld

Zeev Bronfeld has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Protalix BioTherapeutics, Inc., Oramed Pharmaceuticals Inc. and Global Energy Inc. We count 10 filings; the first trade dates from 31 December 2006 and the latest from 2 October 2014.

Market trades split into 2 purchases (€397k) and 3 sales (€8.3M). The net balance comes to €7.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2014 alone, the filings show no purchases and 1 sale.

The latest filing, published on 6 October 2014, reports a transaction in Protalix BioTherapeutics, Inc. The most recent open-market purchase was published on 4 April 2011, 5,698 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.